Neurent Medical
The company develops the NEUROMARK System, a minimally invasive medical device designed to treat chronic rhinitis by targeting overactive posterior nasal nerves. The technology uses low-power radiofrequency energy to create lesions that disrupt these nerves, providing relief from symptoms like congestion, rhinorrhea, and sneezing. The product is marketed to otorhinolaryngology (ENT) surgeons and patients seeking durable alternatives to temporary symptom management.
Visit websiteGalway, Ireland
Healthtech
Medical Devices
ENT Surgery
Funding summary
- Total raised
- €62.5M
- Funding rounds
- 1
Investors in Neurent Medical
Investors on record for Neurent Medical. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Neurent Medical?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors